PL EN


2012 | 3 | 447-452
Article title

Neurologiczne zespoły paranowotworowe

Authors
Content
Contributors
author
References
  • Honnorat J, Viaccoz A. New concepts in paraneoplastic neurological syndromes. Rev Neurol (Paris) 2011; 167: 729−736.
  • Ejma M. Objawy oczne w zespołach paranowotworowych. Pol Przegl Neurol 2009; 5: 139−147.
  • Michalak S. Neurologiczny zespół paranowotworowy na podstawie modelu doświadczalnej choroby nowotworowej u szczura (wątrobiak Morrisa 5123). Rozprawa habilitacyjna. Poznań: Akademia Medyczna; 2004.
  • Brzecka A, Ejma M, Misiuk-Hojło M. Neurologiczne zespoły paranowotworowe w przebiegu raka płuca. Adv Clin Exp Med 2004; 13: 343−347.
  • Vedeler CA, Antoine JC, Giometto B, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 2006; 13: 682−690.
  • Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 2004; 10:7270−7275.
  • Shaygannejad V, Ghasemi M, Rajaee Z. Myasthenia gravis as a presenting feature in a patient with lung cancer: A case report. J Res Med Sci 2011; 16: 229−232.
  • de Beukelaar JW, Smitt PAS. Managing paraneoplastic neurological disorders. Oncologist 2006; 11: 292−305.
  • Matthew LA, Darnell RB. Paraneoplastic neurological degenerations: keys to tumor immunity. Nat Rev Cancer 2004; 4: 36−44.
  • Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349: 1543–1554.
  • Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes.J Neurol Neurosurg Psychiatry 2004; 75: 1135−1140.
  • Isobe K, Nagata R, Ota H, et al. A case of small-cell lung cancer associated with paraneoplastic limbic encephalitis during chemotherapy. Nihon Kokyuki Gakkai Zasshi 2011; 49: 602−606.
  • Jarius J, Hoffmann L, Clover L, et al. Limbic encephalitis: prevelence of paraneoplastic and VGKC antibodies. J Neuroimmunol 2006; 174: 192.
  • Sahu JK, Prasad K. The opsoclonus-myoclonus syndrome. Pract Neurol 2011; 11: 160−166.
  • Jamroz E, Głuszkiewicz E, Madziara W, et al. Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour. Med Wieku Rozwoj 2011;15: 151−156.
  • Kashyap AS, Anand KP, Kashyap S, et al. Peripheral neuropathy. Lancet 2004; 364: 1664.
  • Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 2011; 10: 1098−1107.
  • Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995; 332: 1467–1474.
  • Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol 2005; 18: 598−603.
  • Hassoun N, Agabrya A, Levy Y. Mediastinal cancer presenting as dermatomyositis − a case report. Harefuah 2011; 150: 574−577.
  • Rominiyi O, Broman DM, Rajaganeshan R, et al. Colon cancer presenting with polymyositis-A case report. Int J Surg Case Rep 2011; 2: 225−227.
  • Hunger RE, Dürr C, Brand CU. Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy.Dermatology 2001; 202:123−126.
  • Sampson JB, Smith SM, Smith AG, et al. Paraneoplastic myopathy: response to intravenous immunoglobulin.Neuromuscul Disord 2007; 17: 404−408.
  • Voltz R. Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes. J Neurol 2006; 253(Suppl.5): V33−V38.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-d252c3d9-eced-4d2f-bbe4-1c4ddebdbbeb
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.